Compensatory depression of arterial pressure and reversal of ECG abnormalities by Annona muricata and Curcuma longa in hypertensive Wistar rats

Author(s):  
Olayinka Ayotunde Oridupa ◽  
Ademola Adetokunbo Oyagbemi ◽  
Olumuyiwa Adejumobi ◽  
Folusho Bolawaye Falade ◽  
Ayobami Deborah Obisesan ◽  
...  

Abstract Objectives Increasing hypertension incidence in Sub-Sahara Africa and the current cost of management of the metabolic disorder has necessitated research on medicinal plants employed in African Traditional Medicine for hypertension. Thus, this study evaluated antihypertensive effect of Annona muricata leaves or Curcuma longa rhizomes in experimentally-induced hypertensive male Wistar rats (n=70) which were unilaterally nephrectomized and daily loaded with 1% salt. Cardiovascular and haematological changes, as well as urinalysis were determined. Methods Rats were uninephrectomized and NaCl (1%) included in drinking water for 42 days. Extract-treated hypertensive rats were compared to normotensive, untreated hypertensive and hypertensive rats treated with lisinopril (5 mg/70 kg) or hydrochlorothiazide (12.5 mg/70 kg). A. muricata extract or C. longa extract were administered at 100, 200 or 400 mg/kg. Blood pressure (systolic, diastolic and mean arterial) and electrocardiogram was measured on day 41. Twenty-four-hour urine samples were collected from day 42. Blood samples were collected on day 43 for haematology (PCV, red cell indices, WBC and its differentials, and platelets). Results and Conculsions A. muricata or C. longa extracts caused a decline in elevated blood pressure of hypertensive rats. Heart rate and QT segment reduction coupled with prolonged QRS duration were reversed in extract-treated rats, with significant increases in hemogram parameters indicating increased blood viscosity. Also, leukocyturia, proteinuria and ketonuria with increased urine alkalinity, urobilinogen and specific gravity which are classical indicators of poor prognostic outcomes in hypertension were reversed in extract-treated rats. In conclusion, A. muricata and C. longa have cardioprotective effect with reversal of derangements in haemogram and urinalysis associated with hypertension.

Author(s):  
Olayinka A. Oridupa ◽  
Folusho B. Falade ◽  
Ademola A. Oyagbemi ◽  
Bukola A. Abegunde ◽  
Precious C. Ekwem ◽  
...  

Aims: Oxidative stress sequel to hypertension exacerbates the clinical condition and accelerates associated organopathies, therefore prevention is important. Traditionally in Nigeria, hypertension is treated with Annona muricata L. leaves or Curcuma longa L. rhizomes, two medicinal plants with antioxidant properties. Study Design:  This study assessed the effect of these plants on hypertension-induced oxidative stress in uninephrectomized Wistar rats daily loaded with 1% sodium chloride. Place and Duration of Study: Department of Veterinary Pharmacology and Toxicology Experimental Animal House, University of Ibadan, Nigeria, between August and November 2017. Methodology: Hypertensive rats were treated with methanol extracts of the plants for 42days. Two other groups of hypertensive rats were treated with lisinopril or chlorothiazide. Blood pressure was monitored by non-invasive tail plethysmography using an electro-sphygmomanometer. Oxidative stress markers were determined in blood and tissue (heart, kidney and liver); GPX, GST, GSH, SOD, MDA and NO. Results: Treatment of uninephrectomized rats with A. muricata or C. longa significantly (p<0.0001) decreased blood pressure and MDA, while elevating enzymatic and non-enzymatic antioxidant defense mechanisms of GST, GSH, GPx and SOD, comparable to normotensive rats. NO, the ubiquitous molecule required for basal vascular tone, myocardial contractility regulation and platelet adhesion prevention, was restored in the extract-treated rats. However, hypertensive untreated rats showed evidence of oxidative damages with significant increase in MDA, especially in the heart and liver, with decreases in the antioxidant defense system. Conclusion: Results of this study justified the traditional use of A. muricata or C. longa for management of hypertension in Nigeria and showed that the extracts ameliorated oxidative damage that accompanied hypertension, thus also preventing complications of hypertension.


1970 ◽  
Vol 3 (4) ◽  
pp. 21-38
Author(s):  
Aline Cunha Santos ◽  
Barbra Rafaela de Melo Santos Azevedo ◽  
Nara Kobbaz Pereira ◽  
Roseane de Souza Cândido Irulegui ◽  
Nilo Cesar do Vale Baracho

Objetivo: Avaliar os efeitos cardiovasculares, renais e hepáticos produzidos pela administração crônica de Ayahuasca em ratos hipertensos. Materiais e Métodos: Foram utilizados 27 ratos machos Wistar adultos. Realizou-se nefrectomia unilateral com compressão do parênquima renal, segundo o modelo de Grollman, para induzir hipertensão. Os ratos hipertensos foram divididos em 4 grupos, com  os seguintes tratamentos por gavagem, durante 60 dias: Grupo C (n=7): dose típica (DT) de água uma vez por semana; Grupo A (n=7): DT de Ayahuasca uma vez por semana; Grupo T (n=6): DT de água diariamente; e Grupo Y (n=7): DT de Ayahuasca diariamente. Os ratos tiveram suas pressões aferidas uma vez por semana; após eutanásia, tiveram sangue colhido para análise laboratorial de função renal e hepática e foram reservados o fígado, rim e coração para análise histopatológica. Resultados: A administração de Ayahuasca não produziu alteração significativa nos padrões pressóricos, sistólicos e diastólicos, assim como parece não ter havido alteração histopatológica relevante; TGO e Uréia sérica apresentaram diferença significativa quando comparados os grupos Y e T. Discussão: Não há na literatura científica trabalhos semelhantes, porém os existentes corroboram para uma ação não tóxica do chá. Conclusão: O uso crônico de Ayahuasca em ratos hipertensos não causou alteração significativa da pressão arterial.  Palavras Chave: Ayahuasca, Hipertensão arterial sistêmica, Ratos Wistar.  Objective: To evaluate the cardiovascular, renal and liver produced by chronic administration of Ayahuasca in hypertensive rats. Materials and Methods: 27 adult male Wistar rats. Unilateral nephrectomy was performed with compression of the renal parenchyma, according to the Grollman model, to induce hypertension. The hypertensive rats were divided into four groups, with the following treatments by gavage for 60 days Group C (n = 7): typical dose (DT) of water once a week, Group A (n = 7): DT ayahuasca once a week and Group T (n = 6): DT daily water and Group Y (n = 7): DT daily ayahuasca. Rats pressures were measured once a week and after euthanasia, blood samples were collected for laboratory analysis of renal and hepatic function. The liver, kidney and heart were reserved for histopathological analysis. Results: The administration of Ayahuasca produced no significant change in blood pressure patterns, systolic and diastolic, as seems to have been no significant histopathological changes; SGOT and serum urea showed significant differences when comparing the groups Y and T. Discussion: There are no similar studies in the scientific literature, but the existing ones corroborate for non-toxic action of the tea. Conclusion: Chronic use of Ayahuasca in hypertensive rats caused no significant change in blood pressure.  Keywords: Ayahuasca, Hypertension, Wistar rats.


2011 ◽  
Vol 26 (suppl 1) ◽  
pp. 57-59 ◽  
Author(s):  
Marcio Wilker Soares Campelo ◽  
Ana Paula Bomfim Soares Campelo ◽  
Luiz Gonzaga de França Lopes ◽  
Armenio Aguiar dos Santos ◽  
Sergio Botelho Guimarães ◽  
...  

PURPOSE: To evaluate the effect of Rut-bpy (Cis-[Ru(bpy)2(SO3)(NO)]PF 6), a novel nitric oxide donor in Nω-nitro-L-arginine methyl ester (L-NAME)-induced hypertensive rats. METHODS: Twenty-four male Wistar rats were randomly assigned to four groups (n=6), named according to the treatment applied (G1-Saline, G2-Rut-bpy, G3-L-NAME and G4-L-NAME+Rut-bpy). L-NAME (30 mg/Kg) was injected intraperitoneally 30 minutes before the administration of Rut-bpy (100 mg/Kg). Mean abdominal aorta arterial blood pressure (MAP) was continuously monitored. RESULTS: Mean arterial blood pressure (MAP) in G3 rats rose progressively, reaching 147±16 mmHg compared with 100±19 mm Hg in G1 rats (p<0.05). In G4 rats, treated with L-NAME+Rut-bpy, MAP reached 149+11 mm Hg while in G2 rats, treated with Rut-bpy, MAP values were 106±11 mm Hg. In G1 rats these values decreased progressively reaching 87+14 mm Hg after 30 minutes. An important finding was the maintenance of the MAP throughout the experiment in G2 rats. CONCLUSION: Rut-bpy does not decrease the MAP in L-Name induced hypertensive rats. However, when it is used in anesthetized hypotensive rats a stable blood pressure is obtained.


1999 ◽  
Vol 277 (1) ◽  
pp. H399-H404 ◽  
Author(s):  
Pilar Nava ◽  
Verónica Guarner ◽  
Rosalinda Posadas ◽  
Israel Pérez ◽  
Guadalupe Baños

Insulin-elicited endothelin release in hypertriglyceridemic, hypertensive, hyperinsulinemic (HTG) rats was shown. Weanling male Wistar rats were given 30% sucrose in their drinking water for 20–24 wk. In vitro contractions of aorta and femoral arteries were elicited with 40 mM KCl. Endothelin release induced with KCl plus 50 μU/ml insulin resulted in increases in contractile responses: 41 ± 5.9 and 57 ± 6% for control and 65.5 ± 6 and 95 ± 9% for HTG aortas and femoral arteries, respectively. The endothelin ETB-receptor blocker BQ-788 decreased responses to KCl + insulin by 39 ± 8 and 53 ± 5% in control and 48 ± 13 and 79 ± 3.5% in HTG aortas and femoral arteries, respectively. The ETA-receptor antagonist PD-151242 inhibited these responses by 12 ± 10 and 1 ± 9% in control and by 51.5 ± 9 and 58.5 ± 1% in HTG aortas and femoral arteries, respectively. These results suggest that endothelin may contribute to the hypertension in this model.


Author(s):  
Tosan Peter Omayone ◽  
Samuel Babafemi Olaleye

Abstract Objectives Vanadium has been reported to possess relevant therapeutic properties such as anti-diabetic and anti-tumoral. This study aimed at determining the effects of vanadium on experimentally induced colitis in rats. Methods Forty-five male Wistar rats (103 ± 3.90 g, n=15) were used for this study and were divided into three groups. Group 1 (Untreated control) had nothing added to their drinking, while groups 2 and 3 received sodium metavanadate at a dose of 50 and 200 mg/L respectively in their drinking water for 10 weeks. Colitis was thereafter induced by intra colonic administration of 1.50 mL of 6% acetic acid. Animals were sacrificed on day 0 (pre-induction), three- and seven-days post induction. Blood samples were collected for haematological variables and the distal 8 cm of the colon was collected for macroscopic, histological and biochemical (malondialdehyde-MDA, superoxide dismutase-SOD, catalase-CAT, glutathione peroxidase- GPx and nitrite concentration- NO) assessment. Results Low dose vanadium proved beneficial in ameliorating acetic acid-induced colitis by improving both histopathological and haematological changes. Gross observation showed a faster healing rate in vanadium treated groups (50 and 200 mg/L) compared with untreated control at day 3 (40 and 26.20 vs. 2.50%) and day 7 (80 and 66.70 vs. 42%) respectively. Vanadium also appears to exert its beneficial effects on acetic acid-induced colitis via up regulation of antioxidant enzymes (SOD, CAT, GPx) and NO while decreasing the over production of MDA. Conclusions Vanadium at small concentration functions as an essential trace element and may be able to promote healing process during ulcerative colitis.


2018 ◽  
Vol 48 (4) ◽  
pp. 654-668 ◽  
Author(s):  
HadjMostefa Khelladi ◽  
Djamil Krouf ◽  
Nawal Taleb-Dida

Purpose This paper aims to study the effect of green lemon zest combined with sardine proteins in diabetic hypertensive rats (DHRs). Design/methodology/approach Male Wistar rats (n = 30) weighing 250 ± 10 g were divided into five groups. The first group consumed a diet containing 20 per cent casein (C). The other four groups are rendered diabetic by intraperitoneal injection of streptozotocin (40 mg/kg body weight), then hypertensive by subcutaneous implantation controlled time-release pellet containing ouabain (0.25 mg/pellet). One untreated group (DHR) consumed 20 per cent casein and the three other groups consumed the same diet supplemented with 2 per cent green lemon zest (DHR-lz), or with 20 per cent of sardine protein (group DHR-sp) or with the combination of both sardine proteins and green lemon zest (group DHR-sp + lz). Findings DHRs feeding on the combination of both sardine protein (sp) and lemon zest (lz) induced a significant decrease of diastolic blood pressure and heart rates values compared with DHR (p < 0.05). The HDLC values were increased by +55 per cent in DHR-sp + lz compared with DHR group. Moreover, plasma non-HDLC concentrations were decreased significantly compared to DHR, DHR-lz, DHR-sp and C groups. In DHR-sp + lzvs DHR group, TBARS values were decreased by −25 per cent in the liver. Moreover, kidney TBARS were significantly reduced by −66, −51, −65 and −67 per cent compared with C, DHR, DHR-lz and DHR-sp, respectively. Originality/value These results suggest that consumption of green lemon zest combined with sardine proteins can reduce blood pressure and tissue oxidative damage and, therefore, help to prevent cardiovascular complications in hypertensive diabetic patients.


Sign in / Sign up

Export Citation Format

Share Document